EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lycium Barbarum Polysaccharide Antagonizes Cardiomyocyte Pyroptosis by Inhibiting the Nrf2/NLRP3 Signal Pathway Against Myocardial Ischemia–Reperfusion Injury

Liuxin Wu, Peng Lin, Xiaomeng Yin, Lin Yang, Chunyan Ma, Shulin Wu, Moyan Yang, Guangyuan Yang, Mingyuan Liu

International Journal of Molecular Sciences · 31.03.2026 · 27 (7) · 3198

DOI: 10.3390/ijms27073198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.03.2026. Verfasst von Liuxin Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Jiamusi University, Jiamusi 154003, China. Hauptthemen laut MEDLINE: Pyroptosis, Myocardial Reperfusion Injury, NLR Family, Pyrin Domain-Containing 3 Protein, NF-E2-Related Factor 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Chinese Medicine Administration, Education Department of Heilongjiang Province, Jiamusi University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia–reperfusion injury (MIRI) significantly compromises the clinical benefits of revascularization and constitutes a central pathological mechanism worsening prognosis in myocardial infarction patients. Accordingly, dissecting the molecular mechanisms underlying MIRI and formulating effective therapeutic interventions are of great clinical significance. Lycium barbarum polysaccharide (LBP), the primary active constituent of Lycium barbarum, has garnered considerable attention in the prevention and treatment of cardiovascular diseases due to its anti-inflammatory, antioxidant, vasomotor function-improving, and antithrombotic properties. This study aims to investigate the ability of LBP to alleviate MIRI, with a specific focus on its role in modulating the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome. Myocardial ischemia/reperfusion (I/R) models in rats and hypoxia/reoxygenation (H/R) models in H9c2 cells were established. Myocardial injury and the therapeutic effect of LBP were evaluated by 2,3,5-Triphenyl tetrazolium chloride (TTC) staining, Hematoxylin-eosin (H&E) staining, Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) staining, and Enzyme-linked immunosorbent assay (ELISA). To elucidate the specific mechanism underlying LBP against MIRI, an Nrf2-overexpressing cell line was generated in H9c2 cells, and pharmacological inhibition of Nrf2 with ML385 was applied for complementary validation. The effects of LBP on H/R-induced oxidative stress, inflammatory response (IL-18, IL-1β), and pyroptosis-related protein expression (NLRP3, apoptosis associated speck-like protein containing a CARD (ASC), cysteine-dependent aspartate-specific proteases (caspase)-1, Gasdermin D (GSDMD)) were systematically evaluated. LBP administration conferred robust cardioprotection in I/R rats, as evidenced by a significant reduction in myocardial infarct size, improved preservation of myocardial fiber architecture, and attenuated leakage of cardiac injury biomarkers (lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB)). Mirroring these in vivo findings, LBP pretreatment effectively shielded H9c2 cardiomyocytes from H/R insult, markedly enhancing cell viability while curtailing reactive oxygen species (ROS) accumulation and apoptotic activation. A pivotal finding was the pronounced downregulation of Nrf2 in the H/R group, a deficit that was conclusively reversed by LBP treatment. To decisively establish a causal role for Nrf2, we employed a loss-of-function approach; Nrf2 inhibition completely abrogated the protective benefits of LBP, culminating in exacerbated tissue damage, a surge in ROS, and the upregulation of key pyroptosis effectors (NLRP3, ASC, caspase-1, GSDMD). Conversely, a complementary gain-of-function experiment demonstrated that Nrf2 overexpression alone was sufficient to mimic LBP’s effects, significantly blunting H/R-induced ROS production and pyroptosis. LBP alleviates MIRI by inhibiting pyroptosis through activating the Nrf2/NLRP3 axis, thus representing a promising therapeutic candidate for ischemic heart disease with the potential to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisMyocardial Reperfusion InjuryNLR Family, Pyrin Domain-Containing 3 ProteinNF-E2-Related Factor 2Myocytes, CardiacSignal TransductionDrugs, Chinese HerbalAnimalsRatsMaleRats, Sprague-DawleyCell LineOxidative Stress

Stichwörter der Autor:innen

Lycium barbarum polysaccharideNLRP3 inflammasomeNrf2/NLRP3 signal pathwaymyocardial ischemia reperfusion injuryoxidative stresspyroptosis

Substanzen

lycium barbarum polysaccharideNLR Family, Pyrin Domain-Containing 3 ProteinNF-E2-Related Factor 2Drugs, Chinese HerbalNlrp3 protein, ratNfe2l2 protein, rat

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Jiamusi University, Jiamusi 154003, China.
  • School of Basic Medical Sciences, Jiamusi University, Jiamusi 154003, China.

Förderung

  • Heilongjiang Chinese Medicine Administration
  • Education Department of Heilongjiang Province
  • Jiamusi University
  • Heilongjiang Provincial Natural Science Foundation of China
  • Heilongjiang Provincial Department of Education
  • First Affiliated Hospital of Jiamusi University

Zitieren

APA

Wu, L., Lin, P., Yin, X., Yang, L., Ma, C., Wu, S., Yang, M., Yang, G., & Liu, M. (2026). Lycium Barbarum Polysaccharide Antagonizes Cardiomyocyte Pyroptosis by Inhibiting the Nrf2/NLRP3 Signal Pathway Against Myocardial Ischemia–Reperfusion Injury. International Journal of Molecular Sciences, 27(7), 3198. https://doi.org/10.3390/ijms27073198

Vancouver

Wu L, Lin P, Yin X, Yang L, Ma C, Wu S, et al. Lycium Barbarum Polysaccharide Antagonizes Cardiomyocyte Pyroptosis by Inhibiting the Nrf2/NLRP3 Signal Pathway Against Myocardial Ischemia–Reperfusion Injury. International Journal of Molecular Sciences. 2026;27(7):3198. doi:10.3390/ijms27073198

BibTeX
@article{Wu2026,
  author = {Wu, Liuxin and Lin, Peng and Yin, Xiaomeng and Yang, Lin and Ma, Chunyan and Wu, Shulin and Yang, Moyan and Yang, Guangyuan and Liu, Mingyuan},
  title = {Lycium Barbarum Polysaccharide Antagonizes Cardiomyocyte Pyroptosis by Inhibiting the Nrf2/NLRP3 Signal Pathway Against Myocardial Ischemia–Reperfusion Injury},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3198},
  doi = {10.3390/ijms27073198}
}
Kostenlos starten →